Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.

Autor: Bressler SB, Qin H, Beck RW, Chalam KV, Kim JE, Melia M, Wells JA 3rd, Diabetic Retinopathy Clinical Research Network

Publikováno v: Archives of Ophthalmology; Sep2012, Vol. 130 Issue 9, p1153-1161, 9p

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).

Autor: Glassman AR; Jaeb Center for Health Research, Tampa, Florida. Electronic address: drcrstat2@jaeb.org., Wells JA 3rd; Palmetto Retina Center, Columbia, South Carolina., Josic K; Jaeb Center for Health Research, Tampa, Florida., Maguire MG; Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania., Antoszyk AN; Charlotte Eye, Ear, Nose and Throat Associates, Charlotte, North Carolina., Baker C; Paducah Retinal Center, Paducah, Kentucky., Beaulieu WT; Jaeb Center for Health Research, Tampa, Florida., Elman MJ; Elman Retina Group, Pikesville, Maryland., Jampol LM; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois., Sun JK; Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts.

Publikováno v: Ophthalmology [Ophthalmology] 2020 Sep; Vol. 127 (9), pp. 1201-1210. Date of Electronic Publication: 2020 Mar 29.

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.

Autor: Bressler NM; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Beaulieu WT; Jaeb Center for Health Research, Tampa, Florida., Glassman AR; Jaeb Center for Health Research, Tampa, Florida., Blinder KJ; The Retina Institute, St Louis, Missouri., Bressler SB; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Jampol LM; Feinberg School of Medicine, Northwestern University Medical School, Chicago, Illinois., Melia M; Jaeb Center for Health Research, Tampa, Florida., Wells JA 3rd; Palmetto Retina Center, Columbia, South Carolina.

Publikováno v: JAMA ophthalmology [JAMA Ophthalmol] 2018 Mar 01; Vol. 136 (3), pp. 257-269.

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Autor: Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Bressler NM; Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland3Editor, JAMA Ophthalmology., Avery RL; California Retina Consultants, Santa Barbara., Bakri SJ; Mayo Clinic, Rochester, Minnesota., Boyer DS; Retina Vitreous Associates Medical Group, Keck School of Medicine of University of Southern California, Los Angeles., Brown DM; Retina Consultants of Houston, Baylor College of Medicine, Houston, Texas., Dugel PU; Retinal Consultants of Arizona, Phoenix9University of Southern California Eye Institute, Keck School of Medicine of University of Southern California, Los Angeles., Freund KB; Vitreous-Retina-Macula Consultants of New York, New York University School of Medicine, New York., Glassman AR; Jaeb Center for Health Research, Tampa, Florida., Kim JE; Medical College of Wisconsin, Milwaukee., Martin DF; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Pollack JS; Illinois Retina Associates, Chicago15Department of Ophthalmology, Rush University Medical Center, Chicago, Illinois., Regillo CD; Wills Eye Hospital Retina Service and Mid Atlantic Retina, Philadelphia, Pennsylvania17Department of Ophthalmology, Thomas Jefferson University, Philadelphia, Pennsylvania., Rosenfeld PJ; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida., Schachat AP; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Wells JA 3rd; Palmetto Retina Center, West Columbia, South Carolina.

Publikováno v: JAMA ophthalmology [JAMA Ophthalmol] 2016 Jan; Vol. 134 (1), pp. 95-9.

Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion.

Autor: Wroblewski JJ; Cumberland Valley Retina Consultants, Hagerstown, Maryland 21740, USA. JohnW@retinacare.net, Wells JA 3rd, Gonzales CR

Publikováno v: American journal of ophthalmology [Am J Ophthalmol] 2010 Jan; Vol. 149 (1), pp. 147-54. Date of Electronic Publication: 2009 Oct 28.